Reproductive carrier screening: GP guidance on risk and management – Part 1

   Rated 4.5 / 5 stars

Save

CPD for this activity

Educational Activities (EA)

1 hours

These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

Reviewing Performance (RP)

0.5 hours

These are activities that require reflection on feedback about your work.

Measuring Outcomes (MO)

0 hours

These are activities that use your work data to ensure quality results.

EA
1 mins

Educational Activities (EA)
These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

RP
0.5 mins

Reviewing Performance (RP)
These are activities that require reflection on feedback about your work.

MO
0 mins

Measuring Outcomes (MO)
These are activities that use your work data to ensure quality results.

Listen to the episode

Description

In this episode:

  • Reproductive carrier screening (RCS) should be proactively integrated into preconception care
  • The 3-gene, Medicare-funded panel screens for cystic fibrosis (CF), spinal muscular atrophy (SMA) and fragile X syndrome (FXS)
  • A low-risk carrier screening result is reassuring, but not absolute
  • Partner testing is essential when a patient is identified as a carrier
  • Fragile X results may have implications for the patient’s own health
  • Genetic counselling and clear documentation are critical components of care
  • Healthcare professionals play a critical role in supporting patients to understand and manage RCS and its implications

 

Experts: A/Prof Marina Berbic, Genetic Pathologist
Wendy Bruce, Executive Director of Fragile X Association of Australia

Total time: 58 mins

 

Recommended resources:

 

Last Updated: 20 Jun, 2025

Rate this podcast
Help your colleagues find podcasts they'll enjoy by rating this podcast out of five stars.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Alexander Sweetman

Dr Alexander Sweetman

Insomnia – Drug & Non-Drug Management

Dr Tracy Leong

Dr Tracy Leong

Lung Cancer Screening Has Started – What GPs Need to Know

A/Prof Gary Kilov AM

A/Prof Gary Kilov AM

Continuous Glucose Monitoring (CGM) for Diabetes Management in GP

Prof Rodney Baber AM

Prof Rodney Baber AM

Menopausal Hot Flushes Management

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

A/Prof Marina Berbic

expert

A/Prof Marina Berbic

Genetic Pathologist; Deputy Director - Genetics, Douglass Hanly Moir

Wendy Bruce

expert

Wendy Bruce

Executive Director; Fragile X Association of Australia

Recent articles

Find your area of interest

Share this

You have completed the Educational Activities (EA) component of this activity.

Select ‘Confirm & claim CPD‘ to confirm you have engaged with this activity in its entirety and claim your CPD.

You will be taken to explore further CPD learning available to you.

Menopause and MHT

Multiple sclerosis vs antibody disease

Using SGLT2 to reduce cardiovascular death in T2D

Peripheral arterial disease